...
首页> 外文期刊>Journal of Hainan Medical University >Effect of triple viable capsule combined with antibiotic therapy on the inflammatory factors and intestinal mucosal barrier function in patients with spontaneous bacterial peritonitis
【24h】

Effect of triple viable capsule combined with antibiotic therapy on the inflammatory factors and intestinal mucosal barrier function in patients with spontaneous bacterial peritonitis

机译:三联活菌胶囊联合抗生素治疗对自发性细菌性腹膜炎患者炎症因子和肠黏膜屏障功能的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study the effect of triple viable capsule combined with antibiotic therapy on the inflammatory factors and intestinal mucosal barrier function in patients with spontaneous bacterial peritonitis. Methods: Patients with cirrhosis combined with spontaneous bacterial peritonitis who were treated in Traditional Chinese Medicine Hospital of Shehong County between March 2015 and October 2017 were selected and randomly divided into the observation group who accepted triple viable capsule combined with antibiotic therapy and the control group who accepted conventional symptomatic treatment. The levels of inflammatory factors and intestinal mucosal barrier markers in serum as well as the number of intestinal flora in feces were detected before treatment and 2 weeks after treatment. Results: Compared with those of same group before treatment, PCT, CRP, sTREM-1, MCP-1, TNF-α, IFN-γ, DAO, D-lactic acid, LPS, Occludin and ZO-1 levels in serum as well as the number of enterobacter and enterococcus in feces of both groups of patients were lower whereas the number of bifidobacterium, lactobacillus and clostridium leptum were higher after treatment, and PCT, CRP, sTREM-1, MCP-1, TNF-α, IFN-γ, DAO, D-lactic acid, LPS, Occludin and ZO-1 levels in serum as well as the number of enterobacter and enterococcus in feces of observation group after treatment were lower than those of control group whereas the number of bifidobacterium, lactobacillus and clostridium leptum were higher than those of control group. Conclusion: Triple viable capsule combined with antibiotic therapy can inhibit the secretion of inflammatory cytokines and improve the intestinal mucosal barrier function in patients with spontaneous bacterial peritonitis.
机译:目的:研究三联活胶囊联合抗生素治疗对自发性细菌性腹膜炎患者炎症因子和肠黏膜屏障功能的影响。方法:选择2015年3月至2017年10月在射洪县中医院治疗的肝硬化合并自发性细菌性腹膜炎患者,随机分为观察组,三联活胶囊联合抗生素治疗组和对照组。接受常规对症治疗。在治疗前和治疗后2周检测血清中的炎症因子和肠粘膜屏障标志物的水平,以及粪便中肠道菌群的数量。结果:与治疗前相同组相比,血清中的PCT,CRP,sTREM-1,MCP-1,TNF-α,IFN-γ,DAO,D-乳酸,LPS,Occludin和ZO-1水平两组患者粪便中肠杆菌和肠球菌的数量较低,而治疗后双歧杆菌,乳杆菌和梭状芽胞杆菌的数量较高,而PCT,CRP,sTREM-1,MCP-1,TNF-α,IFN-α观察组治疗后血清中γ,DAO,D-乳酸,LPS,Occludin和ZO-1的水平以及粪便中肠杆菌和肠球菌的数量均低于对照组,而双歧杆菌,乳杆菌和乳酸菌的数量低于对照组。瘦梭状芽胞杆菌高于对照组。结论:三联活菌胶囊联合抗生素治疗可抑制自发性细菌性腹膜炎患者炎性细胞因子的分泌,改善肠粘膜屏障功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号